The market for cardiogenic shock was valued at $3.23 billion globally in 2021 and is anticipated to grow at a 6.2% CAGR in terms of revenue during the forecast period. The global increase in the prevalence of heart diseases, the gradually expanding impact of a sedentary lifestyle, and rising healthcare spending are the main drivers of the cardiogenic shock market's revenue growth. A potentially...